Byrd, Kenneth, and Phu Truong. “Bortezomib in the Treatment of Acquired Von Willebrand Disease Secondary to Monoclonal Gammopathy of Undetermined Significance”. Kansas Journal of Medicine, vol. 7, no. 4, Nov. 2014, pp. 167-70, https://doi.org/10.17161/kjm.v7i4.11507.